Eric Bell
Eric Bell is Managing Director at SpringRock Ventures. He was Vice President of Investment Strategy at Intellectual Ventures and a Venture Capital Investment Professional at Vulcan Capital Management. He also served as a Board Member at OFFOR Health, Opya, CurvaFix, Cyrus Biotechnology, Aqueduct Critical Care, C-SATS, IntraPace, Inc and Advanced Diagnostic Imaging, Inc.
SmileMD raises $5M Series A to expand mobile OR anesthesia services across Central and Southeast Ohio
SmileMD, a Columbus startup that brings anesthesia and mobile operating-room services to dental and medical offices, raised $5 million in a Series A to expand its physician network, services, territory and hire staff while aiming to double sales.
Cyrus Biotechnology Raises $8M Series A Led by Trinity Ventures to Expand Cloud-Based Protein Modeling for Drug Discovery
Cyrus Biotechnology secured $8 million in Series A funding led by Trinity Ventures to advance its cloud-based protein modeling platform, Cyrus Bench, which aids drug discovery. The software builds on the University of Washington's Rosetta platform, enabling researchers to design novel protein configurations for therapeutic applications.
Organizations
See all 16-
SpringRock Ventures Managing Director 2015–present · current
-
OFFOR Health Board Member 2021–2026 · past
-
Opya Board Member 2020–2021 · past
Education
-
The Wharton School MBA, Health Care Management, Finance · 1995–1997
-
University of Pennsylvania MSE, Bioengineering · 1992–1993
-
Worcester Polytechnic Institute BS, Mechanical Engineering · 1989–1992